Imunon, Inc. — Director's Dealing 2023

Mar 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2023-03-17

Reporting Person: Tardugno Michael H (Director, Executive Chairman of Board)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-17	Stock Option (Right to Buy)	$1.32	A	25000	Acquired	2033-03-17	Common Stock (25000)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

F2: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant.